Lecanemab named one of the world's best inventions in 2023 by TIME
Stockholm, October 24, 2023 – BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) and partner Eisai are proud to announce today that TIME has selected lecanemab (lecanemab-irmb, brand name LEQEMBI® in the US and Japan) as one of the Best Inventions of 2023 in the medical care category.Lecanemab is based on BioArctic’s founder Professor Lars Lannfelt’s research. It is the first and only fully approved treatment in the US and Japan for patients with mild cognitive impairment or mild Alzheimer's disease that targets the underlying disease and slows